News tagged with astrazeneca
Pharma giants open up drug patents in new collaboration
Pharmaceutical giants and the UN intellectual property agency launched Wednesday a collaboration to share certain patented drug information with public organisations.
Medicine & Health / Medications
Oct 26, 2011 |
5 / 5 (1) |
2
Ticagrelor: Considerable added benefit for specific patients
Since the start of 2011, the active ingredient ticagrelor can be prescribed in Germany in addition to acetylsalicylic acid (ASA) to avoid blood clots in patients with acute ischaemia of the cardiac muscle. The German Institute ...
Oct 11, 2011 |
not rated yet |
0
Faulty gene connected to ovarian cancer risk
In a new study published in Nature Genetics researchers say that women who possess a fault in a gene named RAD51D have a greater risk of developing ovarian cancer than women who do not have this fault and tests are expect ...
Aug 09, 2011 |
not rated yet |
0
|
More molecules for tuberculosis
Scientists are collaborating on a new international research project to identify antibiotics that can kill tuberculosis and fight resistant strains.
Mar 11, 2011 |
not rated yet |
0
EU steps up generic pharma anti-trust probe
Europe stepped up action against drug companies snarling up the entry of cheaper generic medicines onto markets, announcing Friday spot inspections confirmed by British No.2 AstraZeneca.
Dec 03, 2010 |
not rated yet |
0
AstraZeneca cancer drug carries toxic risks: FDA
An experimental drug developed by AstraZeneca to treat a rare form of thyroid cancer carries "substantial toxicity" risks, the US Food and Drug Administration warned Tuesday.
Medicine & Health / Medications
Nov 30, 2010 |
not rated yet |
0
A better way to target tumors
In the past 40 years, scientists have learned a great deal about how cells become cancerous. Some of that knowledge has translated to new treatments, but most of the time doctors are forced to rely on standard ch ...
Nov 15, 2010 |
5 / 5 (1) |
0
Cholesterol drugs for the healthy still debatable
(AP) -- Should healthy people with low cholesterol take a pill to lower their cholesterol even more in hopes of preventing heart problems? The question is dividing heart doctors and confusing patients.
Medicine & Health / Medications
Jun 28, 2010 |
5 / 5 (2) |
0
Drug companies share data to speed brain research
(AP) -- In an unusual step, a dozen competing drug companies have agreed to share data on thousands of Alzheimer's patients in hopes that the extra information will spark new ideas for treatments.
Jun 11, 2010 |
5 / 5 (2) |
0
A new method for developing safer drugs
Amodiaquine was introduced as an antimalarial drug, but was withdrawn when serious adverse effects were observed. Scientists at the University of Gothenburg, Sweden, have now developed a method that can be used to develop ...
May 10, 2010 |
not rated yet |
0
Takeda renames heartburn drug to avoid errors
(AP) -- Federal regulators said Thursday that Takeda Pharmaceuticals will change the name of a heartburn drug that has repeatedly been confused by pharmacists with drugs meant to treat cancer and other ailments.
Medicine & Health / Medications
Mar 04, 2010 |
not rated yet |
0
FDA confirms benefits of Crestor in more patients
(AP) -- Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain.
Medicine & Health / Medications
Dec 11, 2009 |
4 / 5 (1) |
0
Newer Anti-Clotting Medication Found to Be More Effective
(PhysOrg.com) -- A large head-to-head study of two anti-clotting medications for heart patients has found that the investigational compound ticagrelor (Brilinta) was more effective at reducing cardiovascular death than the ...
Medicine & Health / Medications
Aug 30, 2009 |
4 / 5 (2) |
0
Study shows experimental drug cuts stroke risk
(AP) -- An experimental drug reduces the stroke risk in patients with irregular heartbeats by more than three times, compared with the popular drug warfarin - but possibly at a cost, according to new research released Sunday.
Medicine & Health / Medications
Aug 30, 2009 |
5 / 5 (1) |
0
Project Zero Delay accelerates drug's path to clinical trial
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six ...
Aug 03, 2009 |
not rated yet |
0
AstraZeneca
AstraZeneca plc (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries, as 3 divisions that were spun off from ICI on 1 June 1993. The Company is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
For more information about AstraZeneca, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
